Scientific Journals | American Association for the ...
www.aaas.org › journalsScience Journals. AAAS publishes six respected peer-reviewed journals. Science, the premier global science weekly; Science Signaling, the leading journal of cell signaling and regulatory biology; Science Translational Medicine, integrating medicine, engineering and science to promote human health; Science Advances, an innovative and high-quality open access journal for all the sciences; Science Immunology, research articles that report critical advances in all areas of immunological research
Open access scientific journals online — International ...
www.scientific-publications.netInternational Scientific Publications represents an aggregate of online-based scientific journals with open access, published by Science Events Ltd and peer-reviewed by experts in the relevant field. Open access policy gives us the opportunity to deliver full-text articles from our journals to our readers, free of charge. This allows our authors to reach to a greater audience, increasing the citation rate of their scientific works.
Science | AAAS
https://www.science.orgThe strength of Science and its online journal sites rests with the strengths of its community of authors, who provide cutting-edge research, incisive ...
Browse Journals | AAAS - Science
https://www.science.org/journal24.12.2021 · Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main protease, an enzyme critical to its replication. The molecule can be delivered in pill form, which may lead to a COVID-19 treatment that can be used outside of a hospital setting. See page 1586.
Nature Research
https://www.nature.comFirst published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ...
Browse Journals | AAAS - Science
www.science.org › journalDec 24, 2021 · Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main protease, an enzyme critical to its replication. The molecule can be delivered in pill form, which may lead to a COVID-19 treatment that can be used outside of a hospital setting. See page 1586.